PharmaRelations ApS: Financial statements 2025
CVR: 38215663
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PharmaRelations ApS (CVR 38215663) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 16,777,505 and a net result of DKK -962,688 compared with DKK 253,685 the year before. That is a decrease of 25% compared with the year before. Equity in the 2025 report amounted to DKK 5,612,668. The solvency ratio was 58.9%. The company had 22 employees in the financial year.
- Gross Profit
- DKK 16,777,505
- Profit/Loss
- DKK -962,688
- Equity
- DKK 5,612,668
- Total Assets
- DKK 9,536,907
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 16.8 mio. | -963 t. | 5.6 mio. | 22 |
| 2024 | - | 22.4 mio. | 254 t. | 6.6 mio. | 27 |
| 2023 | - | 23.3 mio. | 699 t. | 6.3 mio. | 28 |
| 2022 | - | 23.6 mio. | 675 t. | 5.6 mio. | 29 |
| 2021 | - | 20.1 mio. | 2.6 mio. | 4.9 mio. | 20 |
Official annual report
How creditworthy is PharmaRelations ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PharmaRelations ApS has published its annual report for 2024. Gross profit came to DKK 22,361,029, and the net result was DKK 253,685.
As of March 27, 2025, Åsa Uppströmer is registered as director of PharmaRelations ApS.
As of March 27, 2025, Fredrik Anjou has stepped down as adm. dir. of PharmaRelations ApS.
About PharmaRelations ApS
PharmaRelations ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Åsa Uppströmer. The company is owned by Kim Raabymagle, Lena Birgitta Andersson Hofsberger and PharmaRelations AB. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 16,777,505 and a net result of DKK -962,688 compared with DKK 253,685 the year before. Equity in the 2025 report amounted to DKK 5,612,668.